Representative issuers:

Dave has represented companies/investment banks on capital market transactions involving issuers across industries, such as: 10X Genomics, Accelerate Diagnostics, Aerohive Networks, Alteryx, Ambarella, Anthera Pharmaceuticals, Apigee, Apptio, Arcadia Biosciences, Aridis Pharmaceuticals, ARMO BioSciences, ASLAN Pharmaceuticals, Atlassian, Audentes Therapeutics, Cision, Crinetics Pharmaceuticals, Dermira, DocuSign, EHang, Eidos Therapeutics, Fantex, FireEye, Five Prime Therapeutics, Global Blood Therapeutics, Gossamer Bio, Gritstone Oncology, Guardant Health, Health Catalyst, HealthEquity, Hyperion Therapeutics, IGM Biosciences, Ignyta, Immune Design, Invitae, Kodiak Sciences, LinkedIn, Livongo Health, MINDBODY, Mobile Iron, Nanthealth, New Relic, Ooma, Otonomy, Principia Biopharma, ProNai, ProQR Therapeutics, PROS Holdings, Rigel Pharmaceuticals, Satsuma Pharmaceuticals, Savara, Shockwave Medical, Sierra Oncology, Snap, Stitch Fix, Sutro Biopharma, Syndax Pharmaceuticals, Tableau Software, Taiwan Liposome Company, Tricida, Trivascular, Uber, ViewRay, Xenon Pharmaceuticals, Yelp, Zendesk, Zscaler, Zymeworks, Zynga.